Holiday Notification: Cayman Chemical will be closed Monday, May 28, 2012, in observance of the Memorial Day holiday.
More…
Please feel free to continue placing orders via our website or via fax at 734-971-3640. You may send an email to customer service at custserv@caymanchem.com , or to technical support at techserv@caymanchem.com which we will respond to the next business day. Cayman will resume regular business hours and shipping schedules on Tuesday, May 29, 2012. Thank you for your patience and understanding.
LY83583 is an inhibitor of soluble guanylate cyclase and of cGMP production. It inhibits soluble guanylate cyclase in human platelets with an IC50 value of 2 µM.1 LY83583 also inhibits leukotriene synthesis in guinea pig lung and rat peritoneal cells with an IC50 value of 1.8 µM and is a noncompetitive inhibitor of glutathione reductase in bovine intestinal mucosa with a Ki value of 3 µM.2,3
1
Mülsch, A., Lückhoff, A., Pohl, U., et al. LY 83583 (6-anilino-5,8-quinolinedione) blocks nitrovasodilator-induced cyclic GMP increases and inhibition of platelet activation. Naunyn Schmiedebergs Arch Pharmacol340119-125(1989).
2
Fleisch, J.H., Haisch, K.D., Spaethe, S.M., et al. Pharmacologic analysis of two novel inhibitors of leukotriene (slow reacting substance) release. J Pharmacol Exp Ther229681-689(1984).
3
Lüönd, R.M., McKie, J.H., and Douglas, K.T. A direct link between LY83583, a selective repressor of cyclic GMP formation, and glutathione metabolism. Biochem Pharmacol452547-2549(1993).
Formal Name
6-(phenylamino)-5,8-quinolinedione
CAS Number
91300-60-6
Molecular Formula
C15H10N2O2
Formula Weight
250.3
Formulation
A crystalline solid
Purity
>99%
Stability
1 year
Storage
-20°C
Shipping
Room temperature
in continental US; may vary elsewhere
SMILES
Copy SMILES to clipboard
O=C1C=C(Nc2ccccc2)C(=O)c2cccnc12
Background Reading
Macleod, K.M., Ng, D.D.W., Harris, K.H., et al. Evidence that cGMP is the mediator of endothelium-dependent inhibition of contractile responses of rat arteries to α-adrenoceptor stimulation. Mol Pharmacol3259-64(1987).
Lüönd, R.M., McKie, J.H., and Douglas, K.T. A direct link between LY83583, a selective repressor of cyclic GMP formation, and glutathione metabolism. Biochem Pharmacol452547-2549(1993).
Barbier, A.J.M., and Lefebvre, R.A. Effect of LY 83583 on relaxation induced non-adrenergic non-cholinergic nerve stimulation and exogenous nitric oxide in the rat gastric fundus. Eur J Pharmacol219331-334(1992).
Kontos, H.A., and Wei, E.P. Hydroxyl radical-dependent inactivation of guanylate cyclase in cerebral arterioles by methylene blue and by LY83583. Stroke24427-434(1993).
Fleisch, J.H., Haisch, K.D., Spaethe, S.M., et al. Pharmacologic analysis of two novel inhibitors of leukotriene (slow reacting substance) release. J Pharmacol Exp Ther229681-689(1984).
Mülsch, A., Lückhoff, A., Pohl, U., et al. LY 83583 (6-anilino-5,8-quinolinedione) blocks nitrovasodilator-induced cyclic GMP increases and inhibition of platelet activation. Naunyn Schmiedebergs Arch Pharmacol340119-125(1989).